LabConnect’s Post

🚀 Excited to have participated in the 41st SPSR Webinar on "Intelligent Drug Delivery System: Futuristic approach towards translation and personalized medicine" organized by Society of Pharmaceutical Sciences and Research (SPSR) on the occasion of National Science Day, February 25, 2024. The webinar was a thought-provoking discussion on the advancements in drug delivery systems and how it can revolutionize the field of medicine. The speakers shared their insights on the potential of personalized medicine and how it can improve patient outcomes..!! #SPSRWebinar #IntelligentDrugDelivery #PersonalizedMedicine #FuturisticApproach #NationalScienceDay🧬 #DrugDelivery #FutureOfMedicine

🚨 Final Registration Reminder! 🚨 Don’t miss out on our upcoming webinar, "Unlocking the Power of Automated Microplate Labeling," on November 12, 2024, at 9 AM Central Time (3 PM UTC) and 1 PM Central Time. This session will explore how automated labeling can enhance accuracy, reduce errors, and streamline your lab workflows. Learn directly from industry experts about the latest tools that can elevate your lab’s efficiency. Whether you work in clinical labs, pharmaceutical companies, or any other scientific field, this webinar is designed for you! 👉 Register now to secure your spot and take the first step toward transforming your lab operations: 🔗9 AM CST: https://hubs.ly/Q02Xm16B0 🔗1 PM CST: https://hubs.ly/Q02XmG1l0 #labautomation #Scinomix #drugdiscovery #genomics #microplates

We’re excited to announce that Amin Rostami-Hodjegan, PhD, SVP of R&D and CSO, will be a part of an upcoming American Association of Pharmaceutical Scientists (AAPS) | @aapscomms webinar! https://lnkd.in/d7BRYqDj   Title: What “Model Master File” (MMF) Is NOT All About! and M&S Facilitating Organ Impairment Clinical Trials Date: August 20, 2024 Time: 12:30 PM - 2:00 PM ET   In this webinar, Amin will explore the role of Model Master Files (MMF) for FDA communication, sharing insights from a recent report by Fang et al. (2024) on best practices for modeling in generic product development. He will also address common misconceptions about MMF and its benefits.   Additionally, Christine Bowman, PhD, and Weize Huang, PharmD PhD, PhD, from Genentech will discuss PBPK modeling in organ impairment clinical trials, sharing retrospective findings and exploring the use of model-generated virtual controls to reduce or replace healthy control subjects. Don’t miss this opportunity to enhance your understanding of MMF and PBPK modeling in clinical trials!   To learn more about this webinar, visit: https://lnkd.in/d7BRYqDj   #Webinar #ClinicalTrials #ModelMasterFile #PBPKModeling #FDA #Pharmaceuticals #DrugDevelopment #VirtualEvent #Modeling #Bioequivalence #Pharmacokinetics #PBPK #Simcyp

Nataraj Dasgupta will be presenting how #AI is an enabler at the #PMSA in Denver, Co. If you are attending the #PMSA2024, add the Monday 4:20pm poster session presentation to your agenda. #RxDataScience

One2Treat is thrilled to be featured in today’s article from Outsourcing-Pharma. Our CEO Sébastien Coppe, discussed the transformative impact of our approach to R&D in the biopharma industry. 🌟 At One2Treat, we're not just following industry trends; we're shaping them and driving them forward. 💡 Our dedication to transforming clinical research ensures that every piece of patient data is valued, every potential treatment is thoroughly assessed, and every decision is informed by the latest advancements in the pharmaceutical sector. 🌐 Join us in revolutionizing the future of biopharma R&D. Together, we can deliver globally beneficial treatments to patients faster than ever before. 💊 https://lnkd.in/eyDG5DZJ #CPHI #DigitalInnovation #ClinicalTrials #PatientCentricDesigns #ReducedSampleSize

Thrilled to have participated in the 76th SPSR Webinar on "Isatin-Based Hybrid Molecules: A New Era in Anticonvulsant Research," organized by the Society of Pharmaceutical Sciences and Research (SPSR). This insightful session explored advancements in anticonvulsant research, providing valuable knowledge on hybrid molecules' therapeutic potential. A huge thanks to SPSR and Mrs. Monika Sabharwal for organizing this impactful webinar and for the opportunity to contribute and learn! #PharmaceuticalResearch #SPSR #Webinar #AnticonvulsantResearch #LearningAndDevelopment

https://lnkd.in/dqVGarwG Today, on International Clinical Trials day, it's important to think about how we can ensure that the European Clinical Trials Ecosystem can evolve to better embrace new technologies, become more patient centred and better meet the the needs of patients, health care systems and clinical trials investigators. Please read this blog authored together with Stefan Schwoch, Max Wegner and the staff at EFPIA - European Federation of Pharmaceutical Industries and Associations.

Reminder: Early registration rates for the 2024 Policy Summit end this FRIDAY, Aug. 23! Why join us? During this 1.5-day deep dive, you'll explore: - Global regulatory strategies and convergence, featuring first-hand learnings from international regulatory agencies - The investment landscape for CGTs, including perspectives from venture capital and pharmaceutical companies - Emerging opportunities in translational science and personalized medicine and so much more! Receive the lowest rates and secure your spot now (link in comments)! #genetherapy #celltherapy #ASGCTadvocacy

Let’s Talk welcomes Jovana Milosevic OLY and Boon Quan Lee, PhD from GenesisCare CRO to explain why Australia is a hot spot for radiopharmaceutical drug development with unique advantages for clinical trials led by pharma and research organizations globally.    Watch the full episode, join the conversation online and be sure to subscribe to this evocative thought leadership series.    Straight Talk. Hard topics. Smart People. https://lnkd.in/gAt5453w    #LetsTalk #Radiopharmaceuticals #Theranostics #ClinicalTrials

❓ How can pharmaceutical companies effectively manage the growing volume of data in precision medicine? In our upcoming webinar with Diaceutics PLC, we’ll explore how scientific engagement and strategic lab partnerships are critical to optimizing precision medicine programs. Learn how biomarker nuances can be better understood and managed, how labs are key stakeholders in the process, and how a multidisciplinary approach can maximize patient identification. By leveraging unique datasets and the expertise of Diaceutics, pharmaceutical companies can action therapeutics for appropriate patients more effectively. Register now to gain insights into optimizing precision medicine through data and lab collaboration: https://buff.ly/493GECd #PrecisionMedicine #Biomarkers #HealthcareInnovation